Pulmonary Artery Denervation Significantly Increases 6-Minute Walk Distance for Patients with Pulmonary Hypertension Associated with Left-Side Heart Failure: A Prospective, Randomized, and Sham-Controlled PADN-5 Study

Hang Zhang,Juan Zhang,Mengxuan Chen,Dujiang Xie,Jing Kan,Wande Yu,Xiaobo Li,Tian Xu,Yue Gu,Jianzeng Dong,Hong Gu,Yaling Han,Shao-Liang Chen
DOI: https://doi.org/10.2139/ssrn.3218702
2018-01-01
Abstract:Background: Heart failure (HF) is associated with sympathetic overactivation. Combined pre-capillary and post-capillary pulmonary hypertension (CpcPH) bears the same pathology as pulmonary arterial hypertension (PAH). Benefits of targeted-PAH medications for CpcPH patients are unknown. Pulmonary artery denervation (PADN), which showed benefit for both PAH and PH patients in a previous consecutive registry study, has not been studied in CpcPH patients using a randomized design. We therefore sought to assess the benefits of PADN for CpcPH patients.
What problem does this paper attempt to address?